The life of a critically ill 65-year-old woman being treated at China's Kunming University hospital intensive care unit with coronavirus was saved after receiving stem cell therapy, South China Morning Post reports.
According to a study published Thursday on Chinaxiv.org., the woman was treated at Baoshan Hospital in Kunming, the capital of southwest China's Yunnan province. After contracting coronavirus, the patient reportedly fought for her life for almost two weeks until she received a shot of umbilical cord stem cells. Four days after receiving the injection, she was said to be able to walk again.
"Although only one case was shown here, it could be very important and inspire similar clinical practices in treating critically ill Covid-19 patients," the study, which has yet to be peer-reviewed, revealed.
The woman reportedly experienced no ill effects from the therapy, and the study suggests treatment might be best used in combination with "other immune-modulating agents."
The World Health Organization (WHO) lists 14 trials of stem cell treatment for Covid-19 in its clinical database. Although this particular form of therapy is controversial, stem cell therapy has shown promise for critically ill patients, generating hope among health and medical professionals.
Dr. Li Honghui has pushed the use of stem cell therapy, highlighting its potential to show results within days.
"We cannot stick to the rules, we must be bold and innovative," he said, per Hunan Daily.